Fidelity-oriented fluorescence imaging probes for beta-galactosidase: From accurate diagnosis to precise treatment

Bin Feng,Feiyi Chu,Anyao Bi,Xueyan Huang,Yanpeng Fang,Meihui Liu,Fei Chen,Yanbing Li,Wenbin Zeng
DOI: https://doi.org/10.1016/j.biotechadv.2023.108244
IF: 17.681
2023-08-31
Biotechnology Advances
Abstract:Beta-galactosidase ( β -gal), a typical glycosidase catalyzing the hydrolysis of glycosidic bonds, is regarded as a vital biomarker for cell senescence and cancer occurrence. Given the advantages of high spatiotemporal resolution, high sensitivity, non-invasiveness, and being free of ionizing radiations, fluorescent imaging technology provides an excellent choice for in vivo imaging of β -gal. In this review, we detail the representative biotech advances of fluorescence imaging probes for β -gal bearing diverse fidelity-oriented improvements to elucidate their future potential in preclinical research and clinical application. Next, we propose the comprehensive design strategies of imaging probes for β -gal with respect of high fidelity. Considering the systematic implementation approaches, a range of high-fidelity imaging-guided theragnostic are adopted for the individual β -gal-associated biological scenarios. Finally, current challenges and future trends are proposed to promote the next development of imaging agents for individual and specific application scenarios.
biotechnology & applied microbiology
What problem does this paper attempt to address?